ADJUNCT TWO was a 26-week, double-blind, parallel-group trial with 835 people randomised 3:1 to liraglutide or placebo (Ahrn et al, 2016)
Primary and secondary antibodies used for immunoblotting are reported in Table S4
These factors dynamically regulate eNOS expression in response to physiological signals
Many face high out-of-pocket costs, especially if they have high deductibles or are underinsured
Staff raised concerns about incomplete characterization, manufacturing-related impurities, aggregation and immune reactions, limited clinical evidence, uncertain effectiveness, and gaps in long-term safety data
Rescue of DNA damage after constricted migration reveals a mechano-regulated threshold for cell cycle